文献速递胸部肿瘤

TRIM27促进肺癌细胞炎症反应的机制研究

[Mechanism of TRIM27 promoting inflammatory response in lung cancer cells].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2021-01-01

该研究检测了10例NSCLC患者癌组织与癌旁组织中TRIM27的表达,并通过siRNA敲减实验探讨TRIM27对TNF-α诱导的IL-6/STAT3信号通路的调控作用。结果显示NSCLC组织中TRIM27表达高于癌旁组织,TRIM27敲减可降低TNF-α诱导的IL-6、VCAM-1和STAT3表达,提示TRIM27可能通过IL-6/STAT3通路促进肺癌炎症反应。

要点

  • NSCLC组织中TRIM27表达高于癌旁正常组织。
  • TRIM27敲减降低TNF-α诱导的IL-6、VCAM-1和STAT3表达。
  • TRIM27可能通过TNF-α/IL-6/STAT3通路促进肺癌炎症反应。

核心结论

  • NSCLC组织和细胞中TRIM27呈高表达,且促进TNF-α基因表达,可能通过调控TNF-α诱导的IL-6/STAT3信号通路促进肺癌炎症反应。

研究设计与样本

  • 收集2018—2019年于温州医科大学附属平阳医院接受手术治疗的NSCLC患者癌组织和正常癌旁组织(距离癌组织5 cm)各10例,采用qRT-PCR和Western blot检测TRIM27表达。
  • TRIM27 siRNA敲减实验分为NC(TRIM27)组、TRIM27 siRNA组、NC(TRIM27)+TNF-α组、TRIM27 siRNA+TNF-α组。
  • IL-6 siRNA敲减实验分为NC(IL-6)组和IL-6 siRNA组,采用Western blot法检测TRIM27、TNFR1、TNFR2及TNFR相关炎症因子蛋白表达。

主要发现

  • 不同分期NSCLC组织中TRIM27表达水平(Ⅰ期2.81±0.58,Ⅱ期3.32±1.38,Ⅲ期3.67±1.24)均高于对应正常癌旁组织(分别为1.01±0.15、0.92±0.10和1.05±0.12,均P<0.05)。
  • NC(TRIM27)组和NC(TRIM27)+TNF-α组细胞中TRIM27 mRNA表达水平分别为0.94±0.12和1.67±0.03,TRIM27蛋白表达水平分别为0.31±0.02和0.38±0.01,差异均有统计学意义(均P<0.05)。
  • NC(TRIM27)+TNF-α组和TRIM27 siRNA+TNF-α组细胞中IL-6 mRNA表达水平分别为11.35±0.12和5.62±0.15,VCAM-1 mRNA表达水平分别为18.75±0.17和9.35±0.11,STAT3 mRNA表达水平分别为16.54±0.10和8.12±0.10,差异均有统计学意义(均P<0.05)。
  • NC(IL-6)组和IL-6 siRNA组细胞中IL-6 mRNA表达水平分别为1.10±0.07和0.52±0.16,STAT3 mRNA表达水平分别为1.01±0.01和0.48±0.12,TRIM27 mRNA表达水平分别为1.03±0.01和0.30±0.11,差异均有统计学意义(均P<0.05)。

临床怎么用

  • TRIM27在NSCLC中高表达且与炎症通路相关,可作为潜在的炎症机制研究方向,但尚不能作为临床决策依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the mechanism of tripartite motif-containing 27 (TRIM27) expression promoting inflammatory response in non-small lung cancer cells. Methods: Ten cases of lung cancer tissues and their matched normal tissue (the distance was 5 cm of the tumor marginal) from patients underwent resection in the People's Hospital of Pingyang Hospital Affiliated to Wenzhou Medical University were collected. The expression of TRIM27 was identified by using real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blot. TRIM27 knockdown experiment included negative control (NC(TRIM27)) group, TRIM27 short interfering RNA (siRNA) group, NC(TRIM27)+ TNF-α group and TRIM27 siRNA+ TNF-α group. Interlukin-6 (IL-6) knockdown experiment included NC(IL-6) group and IL-6 siRNA group. The protein expressions of TRIM27, TNFR1, TNFR2 and some TNFR related inflammation factors were verified by qRT-PCR and WB. Results: The expression levels of TRIM27 in NSCLC tissues of different stages (stage Ⅰ: 2.81±0.58, stage Ⅱ: 3.32±1.38, stage Ⅲ: 3.67±1.24) was higher than that in the adjacent normal tissues (1.01±0.15, 0.92±0.10 and 1.05±0.12, P<0.05). The expression levels of TRIM27 mRNA in NC(TRIM27) group and NC(TRIM27)+ TNF-α group were 0.94±0.12 and 1.67±0.03, and the expression levels of TRIM27 protein were 0.31±0.02 and 0.38±0.01, respectively (P<0.05). The expression levels of IL-6 mRNA in NC(TRIM27)+ TNF-α group and TRIM27 siRNA+ TNF-α group were 11.35±0.12 and 5.62±0.15, respectively, and the expression levels of VCAM-1 mRNA were 18.75±0.17 and 9.35±0.11, respectively. STAT3 mRNA expression levels were 16.54±0.10 and 8.12±0.10, respectively, with statistical significance (P<0.05). The expression levels of IL-6 mRNA in NC(IL-6) group and IL-6 siRNA group were 1.10±0.07 and 0.52±0.16, respectively, and the expression levels of STAT3 mRNA were 1.01±0.01 and 0.48±0.12, respectively. The expression levels of TRIM27 mRNA were 1.03±0.01 and 0.30±0.11, respectively, with statistical significance (P<0.05). Conclusion: The upregulation of TRIM27 in NSCLC tissue and cells promotes the expression of TNF-α, and may activate inflammatory response by regulating TNF-α-induced IL-6/STAT3 signaling pathway. 目的: 探讨三结构域蛋白27(TRIM27)在非小细胞肺癌(NSCLC)细胞炎症反应中的作用机制。 方法: 收集2018—2019年于温州医科大学附属平阳医院接受手术治疗的NSCLC患者的癌组织和正常癌旁组织(距离癌组织5 cm)各10例,利用荧光定量聚合酶链反应(qRT-PCR)和Western blot法检测TRIM27 mRNA和蛋白的表达水平。TRIM27 siRNA敲减实验分为NC(TRIM27)组、TRIM27 siRNA组、NC(TRIM27)+TNF-α组、TRIM27 siRNA+TNF-α组;白细胞介素6(IL-6) siRNA敲减实验分为NC(IL-6)组和IL-6 siRNA组。采用Western blot法检测各组细胞系中TRIM27、肿瘤坏死因子受体1(TNFR1)、TNFR2以及TNFR相关炎症因子蛋白的表达水平。 结果: 不同分期NSCLC组织中TRIM27表达水平(Ⅰ期为2.81±0.58,Ⅱ期为3.32±1.38,Ⅲ期为3.67±1.24)均高于对应正常癌旁组织(分别为1.01±0.15、0.92±0.10和1.05±0.12,均P<0.05)。NC(TRIM27)组和NC(TRIM27)+TNF-α组细胞中TRIM27 mRNA的表达水平分别为0.94±0.12和1.67±0.03,TRIM27蛋白表达水平分别为0.31±0.02和0.38±0.01,差异均有统计学意义(均P<0.05)。NC(TRIM27)+TNF-α组和TRIM27 siRNA+TNF-α组细胞中IL-6 mRNA的表达水平分别为11.35±0.12和5.62±0.15,VCAM-1 mRNA的表达水平分别18.75±0.17和9.35±0.11,STAT3 mRNA表达水平分别16.54±0.10和8.12±0.10,差异均有统计学意义(均P<0.05)。NC(IL-6)组和IL-6 siRNA组细胞中IL-6 mRNA的表达水平分别为1.10±0.07和0.52±0.16,STAT3 mRNA的表达水平分别为1.01±0.01和0.48±0.12,TRIM27 mRNA的表达水平分别为1.03±0.01和0.30±0.11,差异均有统计学意义(均P<0.05)。 结论: NSCLC组织和细胞中,TRIM27呈高表达,且促进TNF-α基因的表达,可能通过调控TNF-α诱导IL-6/STAT3信号通路促进肺癌炎症反应的发生。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Chen EJ, Chen S, Zhou FL, et al. [Mechanism of TRIM27 promoting inflammatory response in lung cancer cells]. Zhonghua Zhong Liu Za Zhi. 2021. PMID: 34695898. doi:10.3760/cma.j.cn112152-20191204-00784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。